Trauson is China's largest manufacturer of pelvic reconstruction plates and trauma surgery products, according to the report. It is also the third largest distributor of spine devices.
If it goes through, the acquisition would give Stryker a foothold in the Chinese orthopedic market, which is expected to be worth $2.7 billion by 2015.
More Articles on Devices:
Mahr Federal Unveils Mobile Surface Measuring Device
TranS1 Reports $4.1M 4Q Revenue, Up 3%
ArthroCAD Completes Financing Round for Total Hip Arthroplasty Development
Stryker Offers to Buy Trauson Holdings in China for $764M FeaturedWritten by Heather Linder | Thursday, 17 January 2013 11:59
Stryker has offered to buy Trauson Holdings in China for $764 million in cash, according to Bloomberg.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.